Translational Cancer Biology

Cancer is one of the leading causes of morbidity and mortality in the western world. Approximately one-third of all adults will face cancer diagnosis during their lifetime, creating an urgent need for more efficient cancer therapies. The Translational Cancer Biology laboratory, led by Academy Professor Kari Alitalo, aims to discover novel mechanisms and drug targets in cancer that contribute to the design of more efficient treatment options for personalized cancer therapy.